sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Zafirlukast

Medicine · Leukotriene Receptor Antagonist

Zafirlukast

Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.

Patient information

Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗

Drug facts

Used for
Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.
How to take it
  • Take zafirlukast tablets exactly as your healthcare provider tells you to take it.
  • Take zafirlukast tablets regularly, even if you do not have asthma symptoms.
  • Do not stop taking or change the dose of your other asthma medicines unless your healthcare provider tells you to.
Do not take if
  • are allergic to zafirlukast or any of the ingredients in zafirlukast tablets. See the end of this leaflet for a complete list of ingredients in zafirlukast tablets.
  • have problems with your liver.

What it is used for

Zafirlukast tablets are a prescription medicine used to help prevent asthma attacks and for the long-term treatment of asthma symptoms in adults and children 5 years and older.

It is not known if zafirlukast tablets are safe and effective when used in children under 5 years old. The effect of zafirlukast tablets on growth in children has not been determined.

Do not take zafirlukast tablets if you need relief right away for a sudden asthma attack. If you get an asthma attack, you should follow the instructions your healthcare provider gave you for treating asthma attacks.

How to take it

  • Take zafirlukast tablets exactly as your healthcare provider tells you to take it.
  • Take zafirlukast tablets regularly, even if you do not have asthma symptoms. Do not change your dose or stop taking zafirlukast tablets without talking to your healthcare provider.
  • Do not stop taking or change the dose of your other asthma medicines unless your healthcare provider tells you to.
  • Take your prescribed dose of zafirlukast tablets by mouth at least 1 hour before or 2 hours after meals.
  • Zafirlukast tablets does not treat the symptoms of a sudden asthma attack. Always have a short-acting beta 2 -agonist medicine (rescue inhaler) with you to treat sudden symptoms. If you do not have a rescue inhaler medicine, talk to your healthcare provider to have one prescribed for you.
  • If you take too much zafirlukast, call your healthcare provider or go to the nearest hospital emergency room right away.

Side effects, and when to stop

Zafirlukast tablets may cause serious side effects, including:

  • Severe liver problems. In some cases, these liver problems can lead to liver failure, the need for a liver transplant or death. Tell your healthcare provider right away if you have:
  • pain or tenderness in the right upper side of your stomach area (abdomen)
  • nausea
  • tiredness
  • itchiness
  • yellowing of your skin or the whites of your eyes
  • flu-like symptoms
  • loss of appetite
  • dark (tea colored) urine
  • Inflammation of your blood vessels. Rarely, this can happen in people with asthma who take zafirlukast tablets. This usually, but not always, happens in people who also take a steroid medicine by mouth that is being stopped or the dose is being lowered. Tell your healthcare provider right away if you have:
  • Changes in behaviour or mood. Tell your healthcare provider if you have changes in your behaviour, problems sleeping or feel very sad.
  • Hypersensitivity reactions. Tell your healthcare provider if you have severe itching, breathing problems, skin rash, skin blisters, or skin redness, or swelling.

The most common side effects of zafirlukast tablets in people 12 years and older include:

The most common side effects of zafirlukast tablets in children 5 to 11 years include:

  • headache
  • stomach pain

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all of the possible side effects of zafirlukast tablets. For more information, ask your healthcare provider or pharmacist.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

You may also report side effects to Aurobindo Pharma USA, Inc. at 1-866-850-2876.

Who should not take it

Do not take zafirlukast tablets if you;

  • are allergic to zafirlukast or any of the ingredients in zafirlukast tablets. See the end of this leaflet for a complete list of ingredients in zafirlukast tablets.
  • have problems with your liver.

What to say before you start

Before you take zafirlukast tablets, tell your healthcare provider if you:

  • have liver problems
  • have any other medical conditions
  • are pregnant or plan to become pregnant. It is not known if zafirlukast tablets will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.
  • are breastfeeding or plan to breastfeed. Zafirlukast can pass into your milk; it is not known whether zafirlukast tablets may harm your baby. Women who are breastfeeding should not take zafirlukast tablets.

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements.

Zafirlukast tablets may affect the way other medicines work, and other medicines may affect how zafirlukast tablets works.

Especially tell your healthcare provider if you take:

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

Storing it

  • Store zafirlukast tablets at 20° to 25°C (68° to 77°F)
  • Keep zafirlukast tablets dry.
  • Keep zafirlukast tablets in a tight closed container and keep zafirlukast tablets out of the light.
  • Keep zafirlukast tablets and all medicines out of the reach of children.

General information about the safe and effective use of zafirlukast tablets.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use zafirlukast tablets for a condition for which it was not prescribed. Do not give zafirlukast tablets to other people, even if they have the same symptoms that you have. They may harm them.

This Patient Information leaflet summarizes the most important information about zafirlukast tablets. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about zafirlukast tablets that is written for healthcare professionals.

For more information, call Aurobindo Pharma USA, Inc. at 1-866-850-2876.

What do zafirlukast tablets look like?

  • the 10 mg tablet is white, round, biconvex, film-coated tablets debossed with “ 1” on one side and “B” on other side
  • the 20 mg tablet is white, round, biconvex, film-coated tablets debossed with “ 2” on one side and “B” on other side.

The brands listed are trademarks of their respective owners and are not trademarks of Aurobindo Pharma Limited.

Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Issued: June 2023

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Zafirlukast; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/zafirlukast

APA 7th

sofidex. (2026, August 3). Zafirlukast. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/zafirlukast

AMA 11th

Zafirlukast. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/zafirlukast

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.